Your English writing platform
Discover LudwigSuggestions(5)
Exact(16)
Seventy-seven (31 %) patients showed an increase of LS ≥ 30%% from baseline at any time during the follow-up.
However, in contrast to the BoNT-Ainjected subjects, the VM VL ratio in placebo subjects was not significantly different from baseline at any time point (figure 4A).
Milk TGF-β1 levels were not statistically significantly different from baseline at any time during the study period (data not shown).
At each post-baseline visit, mean weight had decreased compared to baseline, but mean decreases were not greater than 0.23 kg below baseline at any time point.
For the mouse from the OA + HA group, the total stride time was also essentially constant at approximately 280 milliseconds throughout, and there were no marked changes in individual parameters from baseline at any time.
Potential clinically significant increases in serum creatinine (serum creatinine ≥1.5 mg/dl and at least 50% greater than baseline at any time point through the EOT visit) were more common in telavancin-treated patients (5/25 vs. 2/28).
Similar(44)
Across the two arms (n = 5,145), a total of 3,130 (64.3%) participants did not use ADMs at baseline or at any time during follow-up.
After that, we classified patients according to the occurrence of an increase ≥ 30%% over the baseline value at any time during the follow-up for several reasons.
Significant progression of LS was defined as an increase ≥ 30%% over the baseline value at any time during the follow-up.
Of additional importance is the observation that increases in cTnT occurring at baseline or at any time during follow-up dramatically modulate the risk-prediction capacity of MR-proANP or copeptin.
†Side effects scored as 1 (mild) or higher at baseline or at any time during the study period; extrapyramidal side effects were as defined in CATIE study, with thresholds adjusted for first episode patients.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com